Skip to main content
. 2025 Aug 28;27(12):3306–3317. doi: 10.1093/neuonc/noaf171

Figure 2.

Representative cases of two patients, one MT and the other non-MT showing T2-weighted FLAIR MRI, post-contrast T1-weighted MRI, ADC, and nrCBV at three timepoints to illustrate imaging changes in both patients.

Representative cases. Representative typical MT and non-MT cases. (A) Patient A is a 38-year-old female patient diagnosed with a contrast-enhancing grade 4 IDH-mutant astrocytoma (IDHm-A). (B) Patient B is a 71-year-old female patient diagnosed with a nonenhancing grade 2 IDH-mutant oligodendroglioma (IDHm-O). MT = malignant transformation, IDHm-A = isocitrate dehydrogenase mutant astrocytoma, IDHm-O = isocitrate dehydrogenase mutant oligodendroglioma, ADC = apparent diffusion coefficient, nrCBV = normalized relative cerebral blood volume, Sx = surgery.